(Updated - November 6, 2023 6:57 AM EST)Truist Securities analyst Joon Lee downgraded Corcept Therapeutics (NASDAQ: CORT) from Hold to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE